{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:51:34Z","timestamp":1785876694886,"version":"3.56.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.intimp.2021.107971","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T15:56:19Z","timestamp":1626796579000},"page":"107971","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata"],"prefix":"10.1016","volume":"99","author":[{"given":"Narges","family":"Ghandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Daneshmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3531-2907","authenticated-orcid":false,"given":"Parvaneh","family":"Hatami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robabeh","family":"Abedini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Nasimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7077-1458","authenticated-orcid":false,"given":"Zeinab","family":"Aryanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrence M.","family":"Vance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2021.107971_b0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.autrev.2005.07.001","article-title":"Alopecia areata: A tissue-specific autoimmune disease of the hair follicle","volume":"5","author":"Gilhar","year":"2006","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.intimp.2021.107971_b0010","first-page":"209","article-title":"Alopecia areata: An update","volume":"23","author":"Amin","year":"2013","journal-title":"J Pakistan Assoc Dermatol."},{"key":"10.1016\/j.intimp.2021.107971_b0015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-4362.1996.tb01610.x","article-title":"Profile of alopecia areata in Northern India","volume":"35","author":"SharmaVK","year":"1996","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.intimp.2021.107971_b0020","doi-asserted-by":"crossref","first-page":"26039","DOI":"10.3402\/qhw.v10.26039","article-title":"Experiences and coping behaviours of adolescents in Pakistan with alopecia areata: an interpretative phenomenological analysis","volume":"10","author":"Rafique","year":"2015","journal-title":"Int J Qual Stud Health Well-being"},{"issue":"9","key":"10.1016\/j.intimp.2021.107971_b0025","article-title":"Influence of Narrow-band UVB Phototherapy on Homocysteine Status: A Prospective Study of Patients with Different Cutaneous Disorders","volume":"39","author":"Aryanian","year":"2021","journal-title":"Photomed Laser Surg."},{"issue":"13","key":"10.1016\/j.intimp.2021.107971_b0030","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2147\/CCID.S280855","article-title":"A Retrospective Comparative Study of Two Concentrations of Intralesional Triamcinolone Acetonide in the Treatment of Patchy Alopecia Areata on the Scalp","volume":"2","author":"Muhaidat","year":"2020","journal-title":"Clin Cosmet Investig Dermatol."},{"issue":"2","key":"10.1016\/j.intimp.2021.107971_b0035","first-page":"42","article-title":"Randomized trial of tacrolimus 0.1% ointment versus triamcinolone acetonide 0.1% paste in the treatment of oral pemphigus vulgaris. Iranian","volume":"15","author":"Mohammad-Javad","year":"2012","journal-title":"J. Dermatol."},{"key":"10.1016\/j.intimp.2021.107971_b0040","doi-asserted-by":"crossref","unstructured":"Zeinab Aryanian, Kamran Balighi, Maryam Daneshpazhooh, Emad Karamshahi, Parvaneh Hatami, Azadeh Goodarzi, Mahroo Tajalli, Terrence M. Vance, Rituximab exhibits a better safety profile when used as a first line of treatment for pemphigus vulgaris: A retrospective study, International Immunopharmacology, 96, 2021, 107755, 1567-5769.","DOI":"10.1016\/j.intimp.2021.107755"},{"issue":"8","key":"10.1016\/j.intimp.2021.107971_b0045","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/jdv.12348","article-title":"Pemphigus vulgaris-associated Kaposi's sarcoma: response to paclitaxel and review of the literature","volume":"28","author":"Balighi","year":"2014","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.intimp.2021.107971_b0050","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/DER.0000000000000094","article-title":"Treatment of alopecia areata with topical sensitizers","volume":"26","author":"Sutherland","year":"2015","journal-title":"Dermatitis"},{"issue":"1","key":"10.1016\/j.intimp.2021.107971_b0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1523-1747.2003.12178.x","article-title":"Cytokines and signal transduction pathways mediated by anthralin in alopecia areata-affected Dundee experimental balding rats","volume":"8","author":"Tang","year":"2003","journal-title":"J Investig Dermatol Symp Proc."},{"issue":"4","key":"10.1016\/j.intimp.2021.107971_b0060","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jaad.2015.01.008","article-title":"Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series","volume":"72","author":"Durdu","year":"2015","journal-title":"J Am Acad Dermatol."},{"issue":"3","key":"10.1016\/j.intimp.2021.107971_b0065","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2003.09.032","article-title":"National Alopecia Areata Foundation. Alopecia areata investigational assessment guidelines\u2013Part II. National Alopecia Areata Foundation","volume":"51","author":"Olsen","year":"2004","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.intimp.2021.107971_b0070","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1001\/archderm.138.1.112","article-title":"Diphencyprone for the treatment of alopecia areata: more data and new aspects","volume":"138","author":"Happle","year":"2002","journal-title":"Arch Dermatol."},{"issue":"1","key":"10.1016\/j.intimp.2021.107971_b0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jaad.2017.04.1142","article-title":"Alopecia areata: An appraisal of new treatment approaches and overview of current therapies","volume":"78","author":"Strazzulla","year":"2018","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.intimp.2021.107971_b0080","doi-asserted-by":"crossref","unstructured":"Ramos PM, Anzai A, Duque-Estrada B, Melo DF, Sternberg F, Santos LDN, Alves LD, Mulinari-Brenner F. Consensus on the treatment of alopecia areata - Brazilian Society of Dermatology. An Bras Dermatol. 2020 Oct 8:S0365-0596(20)30235-X. doi: 10.1016\/j.abd.2020.05.006.","DOI":"10.1016\/j.abd.2020.05.006"},{"key":"10.1016\/j.intimp.2021.107971_b0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1067\/mjd.2001.109309","article-title":"The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata","volume":"44","author":"Cotellessa","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2021.107971_b0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-5945-5-6","article-title":"Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population","volume":"5","author":"Aghaei","year":"2005","journal-title":"BMC Dermatol"},{"key":"10.1016\/j.intimp.2021.107971_b0095","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1468-3083.2004.01138.x","article-title":"Topical immunotherapy with diphencyprone in the treatment of extensive and\/or long-lasting alopecia areata","volume":"19","author":"Firooz","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.intimp.2021.107971_b0100","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1468-3083.2007.02411.x","article-title":"Alopecia areata: topical immunotherapy treatment with diphencyprone","volume":"22","author":"Avgerinou","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.intimp.2021.107971_b0105","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jdcr.2019.01.006","article-title":"Case report of novel combination of anthralin and calcipotriene leading to trichologic response in alopecia areata","volume":"5","author":"Krueger","year":"2019","journal-title":"JAAD Case Rep."},{"key":"10.1016\/j.intimp.2021.107971_b0110","doi-asserted-by":"crossref","unstructured":"Shapiro J, Tan J, Tron V. Diphencyprone and minoxidil in alopecia areata: a clinical and immonopathological evaluation.J Invest Dermatol. 1995;104:36S.","DOI":"10.1038\/jid.1995.54"},{"key":"10.1016\/j.intimp.2021.107971_b0115","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2230.1991.tb00339.x","article-title":"Treatment of alopecia totalis with a combination of inosine pranobex and diphencyprone compared to each treatment alone","volume":"16","author":"Berth-Jones","year":"1991","journal-title":"Clin Exp Dermatol."},{"issue":"8","key":"10.1016\/j.intimp.2021.107971_b0120","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00403-019-01940-x","article-title":"Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series","volume":"311","author":"Nasimi","year":"2019","journal-title":"Arch Dermatol Res."},{"key":"10.1016\/j.intimp.2021.107971_b0125","doi-asserted-by":"crossref","unstructured":"Ibrahim SA, Esawy AM, Abdelshafy AS. Treatment of chronic extensive alopecia areata by diphenylcyclopropenone alone versus in combination with anthralin. Dermatol Ther. 2019 Sep;32(5):e13010. doi: 10.1111\/dth.13010. Epub 2019 Jul 8. PMID: 31237076.","DOI":"10.1111\/dth.13010"},{"key":"10.1016\/j.intimp.2021.107971_b0130","first-page":"48","article-title":"Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata","volume":"32","author":"Sotiriadis","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.intimp.2021.107971_b0135","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0190-9622(98)70048-9","article-title":"Efficacy of topical sensitizers in the treatment of alopecia areata","volume":"39","author":"Rokhsar","year":"1998","journal-title":"J Am Acad Dermatol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692100607X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692100607X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T20:13:51Z","timestamp":1730837631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692100607X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":27,"alternative-id":["S156757692100607X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107971","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107971","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107971"}}